| Informazzjoni Bażika | |
| Isem tal-prodott | Amantanamine hydrochloride (Grad Farmaċewtiku) |
| CAS Nru. | 665-66-7 |
| Dehra | Trab kristallin fin abjad |
| Grad | Grad Pharma |
| Solubilità fl-Ilma | Solubbli |
| Ħażna | Aħżen taħt +30°C. |
| Ħajja fuq l-ixkaffa | 2 Snin |
| Pakkett | 25kg/Drum |
Deskrizzjoni tal-Prodott
| Isem tal-Prodott: | Amantanamine hydrochloride |
| Sinonimi: | Amantanamine hydrochloride, 1-Adamantylamine hydrochloride, 1-Aminoadamantane hydrochloride; Hydrochloride (200 mg);1-AdaMantanaMine hydrochloride, 99+% 100GR;1-AdaMantanaMine hydrochloride, 99+% 25GR;1-AdaMantanaMine hydrochloride, 99+% 5GR;1-adamantane amine hydrochloride;1-Aminodamantanamine Hydrochloride; Hydrochloride |
| CAS: | 665-66-7 |
| MF: | C10H18ClN |
| MW: | 187.71 |
| EINECS: | 211-560-2 |
| Kategoriji tal-Prodott: | Viruses tal-Influwenza;API;Intermedji u Kimiċi Fini;Riċettur tad-dopamina;SYMADINE;inibitur;Derivattivi tal-Adamantan;chiral;Adamantanes;Farmaċewtiċi;API;1;665-66-7 |
Użu Klinika
Amantanamine hydrochloridejintuża fit-trattament profilattiku jew sintomatiku tal-influwenza A.
Jintuża wkoll bħala aġent antiparkinsonjan, biex jikkura reazzjonijiet piramidali żejda, u għan-newralġija postherpetika.
Jintuża wkoll antagoinst tar-riċettur NMDA.






